T. Rowe Price Investment Management
ZNTL icon

T. Rowe Price Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

T. Rowe Price Investment Management’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,325,491
Closed -$5.42M – 660
2024
Q2 		$5.42M Sell
1,325,491
-1,993,595
-60% -$22.3M ﹤0.01% 571
2024
Q1 		$52.3M Buy
3,319,086
+977,303
+42% +$13.4M 0.03% 389
2023
Q4 		$35.5M Buy
2,341,783
+369,299
+19% +$5.39M 0.02% 434
2023
Q3 		$39.6M Sell
1,972,484
-26,870
-1% -$682K 0.03% 396
2023
Q2 		$56.4M Sell
1,999,354
-11,055
-0.5% -$265K 0.04% 362
2023
Q1 		$34.6M Sell
2,010,409
-200,033
-9% -$4.05M 0.02% 411
2022
Q4 		$44.5M Buy
2,210,442
+1,773
+0.1% +$38.1K 0.03% 369
2022
Q3 		$47.8M Buy
+2,208,669
New +$60.4M 0.04% 352

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return